Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT03011567
Eligibility Criteria:
Inclusion Criteria:
* Delivery occurred at equal to or greater than 24 0/7 weeks gestational age
* Patient receiving care with the Women's Perinatal Group (Maternal Fetal Medicine practice) or Obstetric Clinic resident services
* Diagnosis of a hypertensive disorder of pregnancy (HDP), including the following:
* Gestational hypertension
* Preeclampsia without severe features
* Preeclampsia with severe features
* Hemolysis, Elevated Liver Enzymes, Low Platelet (HELLP) Syndrome
* Eclampsia
Exclusion Criteria:
* Diagnosis of chronic hypertension or documentation of elevated blood pressures before 20 weeks gestational age.
* Severe hypertension: Patients with at least one severe blood pressure measurement (systolic \>160mmHg or diastolic \>105mmHg) prior to randomization
* Renal dysfunction (Serum creatinine measurement \>1.3mg/dL during the current pregnancy)
* Low platelet count (recorded measurement \<50,000 during hospital admission)
* Significant liver dysfunction (AST or ALT \>500)
* Known sensitivities to ibuprofen or acetaminophen
* Use of therapeutic doses of anticoagulation (low dose anticoagulation used for routine prophylaxis of venous thromboembolism is acceptable)
* Postpartum hemorrhage requiring transfusion
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT03011567
Study Brief:
Protocol Section:
NCT03011567